Latest Articles

All Latest Articles

150178 Articles

Steven M. Peters | Dec 3, 2018 at 12:05 PM EST

Rumor: New AirPod case by April, AirPods in 2020

Sustaining innovations for "Apple's most popular accessory ever."

Evan Comen | Dec 3, 2018 at 11:49 AM EST

America’s Fastest Growing (and Shrinking) Housing Markets

A decade has passed since the U.S. housing market crash and the beginning of the 2008 financial crisis. The typical…

Paul Ausick | Dec 3, 2018 at 11:45 AM EST

Ram Pickup Sales Soar, Ford F-Series Sales Edge Down

Sales of pickups and SUVs carried U.S. automakers Ford and Fiat Chrysler in November. Toyota's midsize Tacoma posted its best-ever…

Chris Lange | Dec 3, 2018 at 11:35 AM EST

What to Expect When Dollar General Reports on Tuesday

Dollar General is scheduled to release its fiscal third-quarter financial results before the markets open on Tuesday, and top and…

Mike Sauter | Dec 3, 2018 at 11:22 AM EST

25 Most Dangerous Cities in America

[cnxvideo id=”911478″ placement=”ros”] Following a nearly two-decade decline in violence in the United States, crime levels rose in 2016 for…

Paul Ausick | Dec 3, 2018 at 11:20 AM EST

Jeep, Ram Send FCA’s November Sales 17% Higher

Fiat Chrysler sales rose by 17% in November led by a gain of 12% in Jeep sales and 44% in…

Grant Suneson | Dec 3, 2018 at 11:10 AM EST

Cities Adding the Most Jobs in Every State

As of September 2018, America’s job market was doing better than it had in decades. Unemployment dropped to 3.7%, the…

Steven M. Peters | Dec 3, 2018 at 11:05 AM EST

Goldman Sachs: Apple smart glasses ‘key milestone’ in 5G adoption

Putting the cart before the horse.

Jon C. Ogg | Dec 3, 2018 at 11:00 AM EST

US Manufacturing Surges in November, With Price Gains Slowing Sharply

Manufacturing saw its activity accelerate in the United States in the month of November, according to the latest report from…

Chris Lange | Dec 3, 2018 at 10:55 AM EST

Global Blood Therapeutics Wins Big With FDA Approval

Global Blood Therapeutics shares shot up on Monday after the company announced that it received an update from the FDA…

Paul Ausick | Dec 3, 2018 at 10:45 AM EST

Ford Sales Drop 7% in November, Cars Down 20%

Ford sales dropped 7% year over year in November with sales of passenger cars down nearly 20%. Shares are rising…

Jon C. Ogg | Dec 3, 2018 at 10:35 AM EST

20 Stocks Loving the China Tariff Delays

24/7 Wall St. has identified 20 companies that are seeing their shares directly benefit as a result of the China…

Steven M. Peters | Dec 3, 2018 at 10:05 AM EST

Jim Cramer on tariff truce: The hedge funds were leaning the wrong way

Mr. Mad Money was not the only one who thought a trade war pause was unlikely.

Chris Lange | Dec 3, 2018 at 9:50 AM EST

Vanda Pharma Nails Midstage Gastroparesis Study

Vanda Pharmaceuticals shares made a solid gain on Monday after the firm announced results from a midstage trial of patients…

Paul Ausick | Dec 3, 2018 at 9:40 AM EST

Tesla Depreciation Case Study a Positive Read on Demand

Analysts at Loup Ventures have calculated that the Tesla Model S depreciates more slowly than competitive vehicles in its class,…

1 … 4,097 4,098 4,099 4,100 4,101 … 10,012

Latest Articles

All Latest Articles

Rumor: New AirPod case by April, AirPods in 2020

America’s Fastest Growing (and Shrinking) Housing Markets

Ram Pickup Sales Soar, Ford F-Series Sales Edge Down

What to Expect When Dollar General Reports on Tuesday

25 Most Dangerous Cities in America

Jeep, Ram Send FCA’s November Sales 17% Higher

Cities Adding the Most Jobs in Every State

Goldman Sachs: Apple smart glasses ‘key milestone’ in 5G adoption

US Manufacturing Surges in November, With Price Gains Slowing Sharply

Global Blood Therapeutics Wins Big With FDA Approval

Ford Sales Drop 7% in November, Cars Down 20%

20 Stocks Loving the China Tariff Delays

Jim Cramer on tariff truce: The hedge funds were leaning the wrong way

Vanda Pharma Nails Midstage Gastroparesis Study

Tesla Depreciation Case Study a Positive Read on Demand

1 Plain-As-Day Dividend King to Buy on the Dip That Has Hiked Its Payout for 70 Consecutive Years

Forget SCHD: This Monthly Dividend Grower Out-Returned It by 38% Over the Last Decade

Claimed Social Security at 62? Here’s Why Your Monthly Benefits Could Still Increase

Claimed Social Security at 62? Here's Why Your Monthly Benefits Could Still Increase

Social Security's $255 Death Benefit Hasn't Changed Since the 1950s. Here's What Surviving Spouses Actually Need.

1 Plain-As-Day Dividend King to Buy on the Dip That Has Hiked Its Payout for 70 Consecutive Years

Forget SCHD: This Monthly Dividend Grower Out-Returned It by 38% Over the Last Decade

Latest Articles

All Latest Articles

Rumor: New AirPod case by April, AirPods in 2020

America’s Fastest Growing (and Shrinking) Housing Markets

Ram Pickup Sales Soar, Ford F-Series Sales Edge Down

What to Expect When Dollar General Reports on Tuesday

25 Most Dangerous Cities in America

Jeep, Ram Send FCA’s November Sales 17% Higher

Cities Adding the Most Jobs in Every State

Goldman Sachs: Apple smart glasses ‘key milestone’ in 5G adoption

US Manufacturing Surges in November, With Price Gains Slowing Sharply

Global Blood Therapeutics Wins Big With FDA Approval

Ford Sales Drop 7% in November, Cars Down 20%

20 Stocks Loving the China Tariff Delays

Jim Cramer on tariff truce: The hedge funds were leaning the wrong way

Vanda Pharma Nails Midstage Gastroparesis Study

Tesla Depreciation Case Study a Positive Read on Demand

1 Plain-As-Day Dividend King to Buy on the Dip That Has Hiked Its Payout for 70 Consecutive Years

Forget SCHD: This Monthly Dividend Grower Out-Returned It by 38% Over the Last Decade

Claimed Social Security at 62? Here’s Why Your Monthly Benefits Could Still Increase

Featured Reads

Claimed Social Security at 62? Here's Why Your Monthly Benefits Could Still Increase

Social Security's $255 Death Benefit Hasn't Changed Since the 1950s. Here's What Surviving Spouses Actually Need.